Genomic Vision

Genomic Vision commercializes its proprietary Molecular Combing Technology to enable high-resolution visualization of single DNA molecules. The company’s solutions are used globally by academic labs, pharmaceutical companies, clinical laboratories, and biomanufacturers. Its platforms support genome stability assessment, detection of large-scale genomic variations, drug discovery targeting DNA replication/repair mechanisms in cancer research, quality control in cell/gene therapy manufacturing processes, and the development of novel companion diagnostic tests—such as TeloSizer® for telomere length measurement. Ongoing collaborations include a four-year program with the Cancer Research Center of Marseille focused on oncology/aging biomarkers using TeloSizer®, expected to yield results by late 2026.